Email this article Miramistin: from dermatovenerology to prevention of coronavirus infection. Literature review
- Authors: Vintserskaya G.A.1, Pritulo O.A.1, Sherengovskaya Y.V.1, Babanin V.A.1, Marakah M.Y.1
-
Affiliations:
- V.I. Vernadsky Crimean Federal University, Medical Academy n.a. S.I. Georgievsky
- Issue: Vol 23, No 5 (2020)
- Pages: 341-346
- Section: CLINICAL PICTURE, DIAGNOSIS, AND THERAPY OF DERMATOSES
- URL: https://rjsvd.com/1560-9588/article/view/63189
- DOI: https://doi.org/10.17816/dv63189
- ID: 63189
Cite item
Open Access
Access granted
Abstract
IMPORTANCE: In 2019, the world faced a serious threat – a new coronavirus infection (COVID-19) –which entailed severe social and economic losses. Considering the massive spread of COVID-19 in 2020, recently, studying the methods of prevention used to prevent the spread of the disease is considered relevant.
RESULTS: We have analyzed scientific publications devoted to the study of prevention in databases, such as Scopus, Web of Science, and CyberLeninka. Antiseptic drugs were of particular interest; thus, this article describes the nonspecific preventive measures with the use of miramistin antiseptic drug. This drug has a wide antimicrobial and antiviral spectrum of action. It has a bactericidal effect on aerobic and anaerobic bacteria, and their association on fungal microflora with significant influences on herpes viruses, human immunodeficiency, hepatitis, and sexually transmitted pathogens. Therefore, for many years, this drug is actively used as a means of prevention. Scientific evidence stating that miramistin can inactivate coronaviruses exists. The obtained data show that miramistin in 0.0001% concentration reduces the infectious activity of human coronavirus almost twice, and miramistin in 0.005% concentration and above completely neutralizes the infectious activity of human coronavirus. It has been proven that miramistin has an immunoadjuvant effect, which leads to increased protective reactions of the skin and enhances skin regeneration due to the activation of cellular and humoral immune responses.
CONCLUSION: Miramistin preparation has the following important advantage: it has a selective effect on pathogens and does not have an adverse effect on body tissues.
Keywords
Full Text
About the authors
Galina A. Vintserskaya
V.I. Vernadsky Crimean Federal University, Medical Academy n.a. S.I. Georgievsky
Author for correspondence.
Email: bulovich31@mail.ru
ORCID iD: 0000-0001-6758-1311
MD, PhD, Docent, Department of Dermatology and Venereology and Cosmetology, Medical Academy n.a. S.I. Georgievsky
Russian Federation, SimferopolO. A. Pritulo
V.I. Vernadsky Crimean Federal University, Medical Academy n.a. S.I. Georgievsky
Email: bulovich31@mail.ru
ORCID iD: 0000-0001-6515-1924
Russian Federation, Simferopol, Republic of Crimea, Russian Federation
Yu. V. Sherengovskaya
V.I. Vernadsky Crimean Federal University, Medical Academy n.a. S.I. Georgievsky
Email: bulovich31@mail.ru
ORCID iD: 0000-0002-9939-2387
Russian Federation, Simferopol, Republic of Crimea, Russian Federation
V. A. Babanin
V.I. Vernadsky Crimean Federal University, Medical Academy n.a. S.I. Georgievsky
Email: bulovich31@mail.ru
ORCID iD: 0000-0003-4248-187X
Russian Federation, Simferopol, Republic of Crimea, Russian Federation
M. Ya.N. Marakah
V.I. Vernadsky Crimean Federal University, Medical Academy n.a. S.I. Georgievsky
Email: bulovich31@mail.ru
ORCID iD: 0000-0002-5579-4413
Russian Federation, Simferopol, Republic of Crimea, Russian Federation
References
- Bagnenko SF, Rassokhin VV, Belyakov NA, Boeva EV, Yastrebova EB. COVID-19 coronavirus infection. Treatment and prevention. HIV Infection and Immunosuppressive Disorders. 2020;12(2):31-56. doi: 10.22328/2077-9828-2020-12-2-31-56. (in Russian)
- Nikiforov VV, Suranova TG, Chernobrovkina TYa, Yankovskaya YaD, Burova SV. New coronavirus infection (COVID-19): clinical and epidemiological aspects. The Russian Archives of Internal Medicine. 2020;10(2):87-93. doi: 10.20514/2226-6704-2020-10-2-87-93. (in Russian)
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
- Lyubimova AV, Aslanov BI, Goncharov AE, Vysotskiy VS, Molchanovskaya MA, Ivanova TG, Vasilev KD. Epidemiology and prevention of coronavirus infection (review). Preventive and clinical medicine. Russian Journal. 2020;(2):17-22. (in Russian).
- Mahe A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246-7. doi: 10.1111/jdv.16471.
- Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3. doi: 10.1111/jdv.16387.
- Khusinova ShA, Aminov ZZ. Activities carried out in primary health care institutions to prevent the spread of COVID-19. Medical Education Today. Russian Journal. 2020;(3):190-201. (in Russian)
- Kaladze NN, Sukhareva IA, Yushchenko AYu. Krivoshein YuS (on the 80th birthday). Crimean Journal of Experimental and Clinical Medicine. Russian Journal. 2019;9(3):83-7. (in Russian)
- Milyavskiy AI, Logadyr TA, Vintserskaya GA, Krivoshein YuS. Effectiveness of miramistin in dermatovenerology. Bulletin of Dermatology and Venereology. Russian Journal. 1996;(2):67-9. (in Russian)
- Vintserskaya GA. Functional activity of nonspecific T-helpers and suppressors in patients with pyodermic and its correction by miramistiin. Dermatology and Venerology. Ukraian Journal. 1997;(2):59-62. (in Russian).
- Krivoshein YuS, Rudko AP, Svistov VV. Miramistin – an antiseptic with immunemodulating and regeneration properties. In: Abstracts of VIІ Russian National Congress «Man and medicine», Moscow, April 10-14, 2000. Moscow; 2000:509. (in Russian)
- Semenova TB, Krivoshein YuS, Nemtinova EB. Treatment and prevention of complications of herpetic infection by various forms of miramistyn. In: Abstracts of VIІ Russian National Congress «Man and medicine», Moscow, April 10-14, 2000. Moscow; 2000:306-7. (in Russian)
- Krivoshein YuS, Andronovskaya IB, Krivorutchenko YuL, Shatrov VA. The effect of miramistyn antiseptic on replication of human immunodeficiency virus in vitro. Trudy KGMU. 2009;5(145):17-25. (in Russian)
- Dunaevskiy AM, Kirichenko IM. Clinical substantiation of Miramistin use in therapy of infectious and inflammatory diseases of respiratory system. Poliklinik. Russian Journal. 2013;(5):6-12. (in Russian)
- Krivoshein YuS, Skuratovich AA, Rudko AP, Tyshkevich LV. Study of the action of surfactants on sexually transmitted disease agents. Bulletin of Dermatology and Venereology. Russian Journal. 1983;59(8):30-3. (in Russian)
- Krivoshein YuS, Shatrov VA. Immunoadjuvant effect of synthetic surfactants. Immunology. Russian Journal. 1990;(2):38-40. (in Russian)
- Sheina AN, Lutoshkina MG. The use of Miramistyn in physiotherapeutic practice. Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2012;(6):51-6. (in Russian)
- Grigoryan AYu, Bezhin AI, Pankrusheva TA, Kobzareva EV, Zhilyaeva LV, Mishina ES. Morphological justification of the use of some antiseptics in the treatment of wounds. Medical News of the North Caucasus. Russian Journal. 2015;10(3):292-5. (in Russian).
- Zhilina SV, Mironov AYu, Polikarpova SV, Pivkina NV. Monitoring of Streptococcus isolated in pyoinflammatory diseases of the skin and soft tissue. Kursk Scientific and Practical Bulletin Man and his Health. Russian Journal. 2009;(2):46-53. (in Russian)
- Khalilov MA. Questions of optimization in local treatment of chronic wounds. Kursk Scientific and Practical Bulletin Man and his Health. Russian Journal. 2009;(3):31-7. (in Russian)
- Blatun LA, Skladan GE, Terekhova RP, Prudnikova SA, Krutikov MG, Andreytseva OI, et al. Fungi infection in surgical department. Systemic and local antifungal therapy. Antibiotics and Chemotherapy. Russian Journal. 2018;63(3-4):37-43. (in Russian)
- Bassetti M, Righi E, Costa A, Fasce R, Pia Molinari M, Rosso R, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis. 2006;6:21.
- Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640-5.
- Meshkov VV, Bogdanov NN, Krivoshein YuS, Chirkov AV. Miramistyn electrophoresis in complex treatment, rehabilitation and secondary prevention of chronic bronchitis and accompanying or complicating pathology: Methodological recommendations. Yalta: Crimean medical Institute; 1997. (in Russian)
- Shatrov VA, Krivoshein YuS. Immunoadjuvant properties of synthetic surfactants. In: Actual Problems of Immunotherapy. Kiev; 1998. (in Russian)
- Bassetti M, Vena A, Giacobbe DR. The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm. Eur J Clin Invest. 2020;50(3):e13209.
- Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158(6):1518-9.
- Salmasi JM, Kazimirsky AN, Antonova EA, Poryadin GV. Evaluation of influence several drugs with local antimicrobial activity against local immunity cells. Medical Council. Russian Journal. 2019;(8):76-82. doi: 10.21518/2079-701X-2019-8-76-82. (in Russian)
- Krivorutchenko YuL. Yuri Semyonovich Krivoshein – scientist, teacher and man. Asklepiy: Russian Historical and Medical Journal. 2010;(1):67-73. (in Russian)
Supplementary files
